Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62016TB0109

    Case T-109/16: Order of the General Court of 18 October 2016 — Laboratoire de la mer v EUIPO — Boehringer Ingelheim Pharma (RESPIMER) (EU trade mark — Opposition proceedings — Application for EU word mark RESPIMER — Earlier EU word mark RESPIMAT — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 — Action manifestly lacking any foundation in law)

    OJ C 462, 12.12.2016, p. 24–25 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    12.12.2016   

    EN

    Official Journal of the European Union

    C 462/24


    Order of the General Court of 18 October 2016 — Laboratoire de la mer v EUIPO — Boehringer Ingelheim Pharma (RESPIMER)

    (Case T-109/16) (1)

    ((EU trade mark - Opposition proceedings - Application for EU word mark RESPIMER - Earlier EU word mark RESPIMAT - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 - Action manifestly lacking any foundation in law))

    (2016/C 462/31)

    Language of the case: English

    Parties

    Applicant: Laboratoire de la mer (Saint-Malo, France) (represented by: S. Szilvasi, lawyer)

    Defendant: European Union Intellectual Property Office (represented by: D. Hanf, acting as Agent)

    Other party to the proceedings before the Board of Appeal of EUIPO: Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim, Germany)

    Re:

    Action brought against the decision of the Fifth Board of Appeal of EUIPO of 21 January 2016 (Case R 3109/2014-5), relating to opposition proceedings between Boehringer Ingelheim Pharma and Laboratoire de la mer.

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Laboratoire de la mer to pay the costs.


    (1)  OJ C 165, 10.5.2016.


    Top